JP2017524358A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2017524358A5 JP2017524358A5 JP2017503551A JP2017503551A JP2017524358A5 JP 2017524358 A5 JP2017524358 A5 JP 2017524358A5 JP 2017503551 A JP2017503551 A JP 2017503551A JP 2017503551 A JP2017503551 A JP 2017503551A JP 2017524358 A5 JP2017524358 A5 JP 2017524358A5
- Authority
- JP
- Japan
- Prior art keywords
- protein
- sequence
- seq
- peptide chain
- allergy
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
- 108090000623 proteins and genes Proteins 0.000 claims description 63
- 102000004169 proteins and genes Human genes 0.000 claims description 63
- 239000012634 fragment Substances 0.000 claims description 25
- 108090000765 processed proteins & peptides Proteins 0.000 claims description 21
- 206010020751 Hypersensitivity Diseases 0.000 claims description 17
- 208000026935 allergic disease Diseases 0.000 claims description 17
- 230000007815 allergy Effects 0.000 claims description 17
- 238000000034 method Methods 0.000 claims description 16
- 241000283073 Equus caballus Species 0.000 claims description 10
- 239000013566 allergen Substances 0.000 claims description 8
- 108020004707 nucleic acids Proteins 0.000 claims description 7
- 102000039446 nucleic acids Human genes 0.000 claims description 7
- 150000007523 nucleic acids Chemical class 0.000 claims description 7
- 239000007787 solid Substances 0.000 claims description 6
- 241001465754 Metazoa Species 0.000 claims description 5
- 241000283086 Equidae Species 0.000 claims description 4
- 108060003951 Immunoglobulin Proteins 0.000 claims description 4
- 125000003275 alpha amino acid group Chemical group 0.000 claims description 4
- 210000001124 body fluid Anatomy 0.000 claims description 4
- 239000010839 body fluid Substances 0.000 claims description 4
- 102000018358 immunoglobulin Human genes 0.000 claims description 4
- 238000002405 diagnostic procedure Methods 0.000 claims description 3
- 238000011156 evaluation Methods 0.000 claims description 2
- 230000006058 immune tolerance Effects 0.000 claims description 2
- 238000009169 immunotherapy Methods 0.000 claims description 2
- 238000000338 in vitro Methods 0.000 claims description 2
- 238000000746 purification Methods 0.000 claims 1
- 239000002773 nucleotide Substances 0.000 description 3
- 125000003729 nucleotide group Chemical group 0.000 description 3
- 239000003153 chemical reaction reagent Substances 0.000 description 2
- 238000001514 detection method Methods 0.000 description 2
- 238000003745 diagnosis Methods 0.000 description 2
- 210000002966 serum Anatomy 0.000 description 2
- 108010058683 Immobilized Proteins Proteins 0.000 description 1
- 239000000020 Nitrocellulose Substances 0.000 description 1
- 101710100170 Unknown protein Proteins 0.000 description 1
- 230000009260 cross reactivity Effects 0.000 description 1
- 238000012258 culturing Methods 0.000 description 1
- 239000000428 dust Substances 0.000 description 1
- 239000011521 glass Substances 0.000 description 1
- 229940049261 horse skin extract Drugs 0.000 description 1
- 238000004519 manufacturing process Methods 0.000 description 1
- 238000002493 microarray Methods 0.000 description 1
- 229920001220 nitrocellulos Polymers 0.000 description 1
- 239000004033 plastic Substances 0.000 description 1
- 229910052710 silicon Inorganic materials 0.000 description 1
- 239000010703 silicon Substances 0.000 description 1
- 239000007790 solid phase Substances 0.000 description 1
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| SE1450907-9 | 2014-07-21 | ||
| SE1450907 | 2014-07-21 | ||
| PCT/SE2015/050828 WO2016013971A1 (en) | 2014-07-21 | 2015-07-20 | Novel allergen |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| JP2017524358A JP2017524358A (ja) | 2017-08-31 |
| JP2017524358A5 true JP2017524358A5 (enExample) | 2018-08-16 |
| JP6785216B2 JP6785216B2 (ja) | 2020-11-18 |
Family
ID=53872123
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2017503551A Active JP6785216B2 (ja) | 2014-07-21 | 2015-07-20 | 新規アレルゲン |
Country Status (10)
| Country | Link |
|---|---|
| US (1) | US10753946B2 (enExample) |
| EP (1) | EP3171890B1 (enExample) |
| JP (1) | JP6785216B2 (enExample) |
| CN (1) | CN106604929B (enExample) |
| AU (1) | AU2015294723B2 (enExample) |
| CA (1) | CA2955348A1 (enExample) |
| DK (1) | DK3171890T3 (enExample) |
| ES (1) | ES2856128T3 (enExample) |
| RU (1) | RU2017104910A (enExample) |
| WO (1) | WO2016013971A1 (enExample) |
Family Cites Families (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US6019972A (en) * | 1989-11-03 | 2000-02-01 | Immulogic Pharmaceutical Corporation | Peptides of human T cell reactive feline protein (TRFP) |
| EP1195606A1 (en) | 2000-10-03 | 2002-04-10 | VBC-Genomics Forschungsges.m.b.H. | Allergen-microarray assay |
| WO2011133105A1 (en) * | 2010-04-23 | 2011-10-27 | Phadia Ab | Novel allergen |
-
2015
- 2015-07-20 RU RU2017104910A patent/RU2017104910A/ru not_active Application Discontinuation
- 2015-07-20 CA CA2955348A patent/CA2955348A1/en active Pending
- 2015-07-20 EP EP15750835.9A patent/EP3171890B1/en active Active
- 2015-07-20 WO PCT/SE2015/050828 patent/WO2016013971A1/en not_active Ceased
- 2015-07-20 DK DK15750835.9T patent/DK3171890T3/da active
- 2015-07-20 JP JP2017503551A patent/JP6785216B2/ja active Active
- 2015-07-20 ES ES15750835T patent/ES2856128T3/es active Active
- 2015-07-20 AU AU2015294723A patent/AU2015294723B2/en active Active
- 2015-07-20 US US15/327,253 patent/US10753946B2/en active Active
- 2015-07-20 CN CN201580038584.4A patent/CN106604929B/zh active Active
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| EP3855186B1 (en) | A method for determining the efficacy of a sars-cov-2 vaccine | |
| Shiakolas et al. | Cross-reactive coronavirus antibodies with diverse epitope specificities and Fc effector functions | |
| JP2016519932A5 (enExample) | ||
| JP2020530285A5 (enExample) | ||
| CN112114150B (zh) | 用于诊断海鲜过敏的方法及产品 | |
| JP2012515551A5 (enExample) | ||
| JP2014502253A5 (enExample) | ||
| JP2015527365A5 (enExample) | ||
| JP2017532544A5 (enExample) | ||
| JP2012515157A5 (enExample) | ||
| JP2013508719A5 (enExample) | ||
| Khan et al. | IgY‐binding peptide screened from a random peptide library as a ligand for IgY purification | |
| JP2019527033A5 (enExample) | ||
| RU2012137304A (ru) | Рекомбинантные белки для применения в вакцине, антитела к указанным белкам и диагностические и терапевтические способы, включающие указанное | |
| JP2017524358A5 (enExample) | ||
| CN103772509A (zh) | 一种艰难梭菌毒素a/b的融合蛋白及其编码基因与应用 | |
| US8324345B2 (en) | HLA-binding peptide, precursor thereof, DNA fragment and recombinant vector encoding the same | |
| CN105273082A (zh) | 一种gfp多克隆抗体的制备方法 | |
| Rasri et al. | Generation of a single-chain variable fragment antibody against feline immunoglobulin G for biosensor applications | |
| RU2017104910A (ru) | Новый аллерген | |
| JP4597172B2 (ja) | ウシミオグロビン部分ペプチドに対する抗体、及び当該抗体を用いた検査方法並びに検査用キット | |
| CN108148124A (zh) | 一种人hnrpa0多肽及其抗体制备方法 | |
| JP2016175891A5 (enExample) | ||
| Burciaga-Flores et al. | A New Approach in DENV Diagnostic based on Linear Peptides Obtained by Phage Display | |
| CN108148126A (zh) | 一种人c21orf13多肽及其抗体制备方法 |